Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TKT | P29401 | 6/20 | 0.51 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30758706 | 1.00 | TKT (0.51) | TKTHSP90AA1LMNADRD4 | |
| Hydrochloric Acid SCHEMBL1326627 | 0.99 | TKT (0.50) | TKTHSP90AA1LMNADRD4 | |
| Hydrochloric Acid SCHEMBL29404983 | 0.99 | TKT (0.50) | TKTHSP90AA1LMNADRD4 | |
| Hydrochloric Acid SCHEMBL9000282 | 0.98 | TKT (0.49) | TKTHSP90AA1LMNADRD4 | |
| Sulfuric Acid SCHEMBL27790987 | 0.94 | TKT (0.49) | TKTHSP90AA1LMNA | |
| Nitric Acid SCHEMBL27791065 | 0.92 | TKT (0.47) | TKTHSP90AA1LMNA | |
| Nitric Acid SCHEMBL27769557 | 0.92 | TKT (0.47) | TKTHSP90AA1LMNA | |
| Bromide SCHEMBL29044448 | 0.92 | TKT (0.46) | TKTHSP90AA1LMNADRD4 | |
| Quinoline SCHEMBL27627708 | 0.88 | TKT (0.42) | TKTHSP90AA1DRD4 | |
| SCHEMBL27941838 | 0.88 | TKT (0.41) | TKTHSP90AA1LMNADRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110139713-A1 | METHOD OF TREATMENT FOR WASTE WATER USING MICROBIALGROWTH PROMOTER | NRP GROUP, INC. | 2011-06-16 | — | — | US | claimed |
| US-7629179-B2 | Surfaces coated with target-induced fluorescent compounds for detection of target elements | UNIVERSITY OF NORTH DAKOTA (US) | 2009-12-08 | — | — | US | claimed |
| US-20060199281-A1 | Nanoparticle linked with 2,3-diaminonapthalene | THE UNIVERSITY OF NORTH DAKOTA | 2006-09-07 | — | — | US | claimed |
| CN-117550963-B | Preparation method of acetyl butanediol | 济南悟通生物科技有限公司 | 2024-04-16 | — | — | CN | disclosed |
| CN-117550963-A | Preparation method of acetyl butanediol | 济南悟通生物科技有限公司 | 2024-02-13 | — | — | CN | disclosed |
| US-20230058125-A1 | NONVISUAL INDICATION OF AN UNWANTED CHEMICAL IN AN INGESTIBLE SUBSTANCE | HOLMES STEPHEN F (US) | 2023-02-23 | — | — | US | disclosed |
| US-20230058125-A1 | NONVISUAL INDICATION OF AN UNWANTED CHEMICAL IN AN INGESTIBLE SUBSTANCE | HOLMES STEPHEN F (US) | 2023-02-23 | — | — | US | disclosed |
| CN-215931679-U | Colloidal gold test paper for rapidly detecting vitamin B1 in food | 深圳大学 | 2022-03-01 | — | — | CN | disclosed |
| US-20200116684-A1 | NONVISUAL INDICATION OF AN UNWANTED CHEMICAL IN AN INGESTIBLE SUBSTANCE | HOLMES STEPHEN F (US) | 2020-04-16 | — | — | US | disclosed |
| WO-2016061490-A1 | NONVISUAL INDICATION OF AN UNWANTED CHEMICAL IN AN INGESTIBLE SUBSTANCE | HOLMES STEPHEN F (US) | 2016-04-21 | — | — | WO | disclosed |
| CN-105315272-A | Method for preparing thiamine hydrochloride crystal product | UNIV TIANJIN | 2016-02-10 | — | — | CN | disclosed |
| US-20060178322-A1 | Methods for indentifying compounds that modulate an enzyme involved in riboflavin metabolism in a pathogenic microorganism | SCHECHTER ALAN M | 2006-08-10 | — | — | US | disclosed |
| US-20060069139-A1 | Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof | RENOPHARM LTD. (IL) | 2006-03-30 | — | — | US | disclosed |
| US-20060069138-A1 | Thiazole-based nitric oxide donors having alkyl substuent(s) and uses thereof | RENOPHARM LTD. (IL) | 2006-03-30 | — | — | US | disclosed |
| US-20060063224-A1 | Method for the identification and treatment of pathogenic microorganism infections by inhibiting one or more enzymes in an essential metabolic pathway | SCHECHTER ALAN M | 2006-03-23 | — | — | US | disclosed |
| WO-2005105765-A1 | NITRIC OXIDE DONORS AND USES THEREOF | RENOPHARM LTD. (IL) | 2005-11-10 | — | — | WO | disclosed |
| WO-2005105065-A2 | THIAZOLE-BASED NITRIC OXIDE DONORS FOR TREATING INFLAMMATORY BOWEL DISEASES | RENOPHARM LTD. (IL) | 2005-11-10 | — | — | WO | disclosed |
| US-6955890-B2 | Method for the identification and treatment of pathogenic microorganisms infections by inhibiting one or more enzymes in an essential metabolic pathway | PYRO PHARMACEUTICALS, INC. (US) | 2005-10-18 | — | — | US | disclosed |
| US-20040006040-A1 | Method for the identification and treatment of pathogenic microorganism infections by inhibiting one or more enzymes in an essential metabolic pathway and compounds and pharmaceutical compositions useful therefor | PYRO PHARMACEUTICALS, INC. | 2004-01-08 | — | — | US | disclosed |
| US-20030180830-A1 | Method for the identification and treatment of pathogenic microorganism infections by inhibiting one or more enzymes in an essential metabolic pathway | PYRO PHARMACEUTICALS, INC. | 2003-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178322-A1 | Methods for indentifying compounds that modulate an enzyme involved in riboflavin metabolism in a pathogenic microorganism | BLVRB, IMPDH1, IMPDH2 | TKT 162/4885HSP90AA1 3145/4885LMNA 2663/4885 |
| US-20040006040-A1 | Method for the identification and treatment of pathogenic microorganism infections by inhibiting one or more enzymes in an essential metabolic pathway and compounds and pharmaceutical compositions useful therefor | CYP51A1, ME1, BPGM | TKT 24/4885HSP90AA1 3513/4885LMNA 3872/4885 |
| US-20060069139-A1 | Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof | NOS2, NOS1, NOS3 | TKT 388/4885HSP90AA1 1521/4885LMNA 4082/4885 |
| US-20060069138-A1 | Thiazole-based nitric oxide donors having alkyl substuent(s) and uses thereof | NOS1, NOS2, NOS3 | TKT 444/4885HSP90AA1 2425/4885LMNA 3851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.